​Effects of the "Big Squeeze" can be seen in manufacturer budget cuts, restricted and/or misallocated sales resources, incorrect financial accruals, investment uncertainty, and increased risk of inaccurate forecasting. Another impact is the growing cost burden that patients face as a result of expanding access controls and cost management.

These factors are today prompting patient support programs to play a crucial role in filling the gap between patient cost exposure and affordability. As market complexity and margin pressure grow, manufacturers must understand and respond to the challenges their support programs are facing.

In this session we will discuss:

  • Rising trends of patient cost exposure and demand for support
  • Current impact and future risks of deductible accumulators and copay maximizers
  • Holistic patient management beyond the co-pay card
  • Implications of potential policy changes